The company’s consulting, analytics, and reporting capabilities provided through their platform, ValueTrak ensure launch success and help optimize the patient journey
ORCHARD PARK, NY — December 20, 2017 – ValueCentric, innovators in product and patient analytics, today celebrates a milestone in their delivery of Specialty Data aggregation, analytics, reporting, and consulting services to the industry. In the past twelve months, the company has been selected to deliver its Specialty Data Services for 10 new product launches. For all customers, ValueCentric is delivering pre-launch consulting, and those clients with launched products are utilizing the ValueTrak platform to monitor the patient journey on a daily basis and maximize patient utilization. The growth is driven by innovations in their analytics platform coupled with the consultative services offered pre-launch to help develop data agreements and contract strategies.
“ValueCentric is immensely proud of our growth in Specialty Services. Our engagement typically starts very early in the product lifecycle with data contract consulting, where we help Manufacturers select the proper data for optimal patient reporting,” explained John Giannouris, Vice President of Specialty Pharma Services for ValueCentric. “Once sound data contracts are in place and data starts flowing, the value of the analytics can be recognized immediately. ValueTrak aggregates a variety of data sources and presents the data in an easy-to-use reporting platform. Our platform is truly what sets us apart from the other data aggregators; we do it all, from data consulting, to data collection, aggregation, analytics, and reporting. Our customers appreciate the convenience of selecting one partner for all Specialty data activities, it simplifies the process,” said Giannouris.
ValueCentric has built a strong reputation in the industry with their reporting and analytics platform; with Specialty customers, their services run even deeper. Manufacturers of Specialty products look to ValueCentric during the data contracting phase to help ensure the proper data is identified and requested based on individual product needs. Their experience with many launches ranging across a breadth of therapeutic categories gives them an advantage and a pool of information to provide best practices based on unique therapy characteristics. “ValueCentric provided a successful and comprehensive roadmap for our data integration, they worked seamlessly with our key customers and leveraged their existing infrastructure and proven methods to ease the transition with our new organization,” said a senior member of the managed markets team at a Massachusetts-based startup biotech customer of ValueCentric’s.
The ValueCentric consulting team has a combined 50+ years of experience in the Specialty data realm. The best practice templates that are implemented with our customers get their product launches off to a strong start, and the reporting and analytics available in the ValueTrak platform ensure the proper metrics are monitored with alerts for critical issues affecting patient care. “2017 was a banner year for us, but 2018 is on track to be even stronger. We’re thrilled to be viewed as trusted advisors to the industry, helping ensure a smooth launch for many life-saving treatments, and we are dedicated to continue to innovate and grow our platform and services to meet the needs of our customers,” said Giannouris.
For information about their Specialty data consulting, aggregation, and analytics services, visit www.valuecentric.com/specialty or contact firstname.lastname@example.org
ValueCentric is the leading data aggregation, analytics, and reporting platform for healthcare manufacturers and their delivery partners. Its innovative technologies cleanse, normalize, and integrate data to provide a complete picture of the product and patient journey for a variety of manufacturers, including Specialty, Branded, Generic, and Medical Products companies. Their cloud-based platform, ValueTrak, enables dynamic data sharing to achieve operational efficiencies, improve market access, and optimize the ability to serve patient needs.